OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy
Duo Zhang, Albert M. Li, Guanghui Hu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 3, pp. 517-534.e8
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Emerging therapies in cancer metabolism
Yi Xiao, Tian‐Jian Yu, Ying Xu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1283-1303
Open Access | Times Cited: 91

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 60

Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma
Liren Zhang, Jiali Xu, Suiqing Zhou, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 1, pp. 82-98
Closed Access | Times Cited: 58

Metabolic heterogeneity in cancer
Margherita Demicco, Xiao‐Zheng Liu, Katharina Leithner, et al.
Nature Metabolism (2024) Vol. 6, Iss. 1, pp. 18-38
Closed Access | Times Cited: 53

Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma
LI Guan-zhang, Di Wang, You Zhai, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1696-1710.e10
Open Access | Times Cited: 34

Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism
Fan Yang, Gloria Lee, Yi Fan
Angiogenesis (2024) Vol. 27, Iss. 3, pp. 333-349
Open Access | Times Cited: 20

Serine synthesis sustains macrophage IL-1β production via NAD+-dependent protein acetylation
Chuanlong Wang, Qingyi Chen, Siyuan Chen, et al.
Molecular Cell (2024) Vol. 84, Iss. 4, pp. 744-759.e6
Open Access | Times Cited: 18

FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy
Haiwei Ni, Zachary J. Reitman, Wei Zou, et al.
Nature Cancer (2025)
Closed Access | Times Cited: 4

The integrated stress response in cancer progression: a force for plasticity and resistance
Caleb L. Lines, Morgan J. McGrath, Tanis J. Dorwart, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 24

Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse
Yulin Zhang, Kaiyan Xi, Zhipeng Fu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14

The potential and promise for clinical application of adoptive T cell therapy in cancer
Yinqi Li, Yeteng Zheng, Taiqing Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12

A comprehensive review on signaling attributes of serine and serine metabolism in health and disease
Di Wu, Kejia Zhang, Faheem Ahmed Khan, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129607-129607
Closed Access | Times Cited: 11

Targeting PKM2 signaling cascade with salvianic acid A normalizes tumor blood vessels to facilitate chemotherapeutic drug delivery
Cheng Qian, Yueke Zhou, Teng Zhang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2077-2096
Open Access | Times Cited: 10

PHGDH: a novel therapeutic target in cancer
Chae Min Lee, Yeseong Hwang, Minki Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 7, pp. 1513-1522
Open Access | Times Cited: 9

Activating transcription factor 4: a regulator of stress response in human cancers
Di Wu, Jie Liang
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8

Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8

STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1

METTL1 coordinates cutaneous squamous cell carcinoma progression via the m7G modification of the ATF4 mRNA
Xinru Zhang, Tong Chen, Fanrong Zhang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1

CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors
Jiahao Liu, Xiaofei Jiao, Ding Ma, et al.
Med (2024) Vol. 5, Iss. 6, pp. 530-549
Closed Access | Times Cited: 7

Cycling back to folate metabolism in cancer
Younghwan Lee, Karen H. Vousden, Marc Hennequart
Nature Cancer (2024) Vol. 5, Iss. 5, pp. 701-715
Open Access | Times Cited: 7

Targeting one‐carbon metabolism for cancer immunotherapy
Xinxin Ren, Xiang Wang, Guowan Zheng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6

Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update
Roa Alsajjan, Warren Mason
Current Oncology (2023) Vol. 30, Iss. 9, pp. 8501-8549
Open Access | Times Cited: 14

Spatial analysis of tissue immunity and vascularity by light sheet fluorescence microscopy
Duo Zhang, Abigail H. Cleveland, Elisavet Krimitza, et al.
Nature Protocols (2024) Vol. 19, Iss. 4, pp. 1053-1082
Closed Access | Times Cited: 5

SAH is a major metabolic sensor mediating worsening metabolic crosstalk in metabolic syndrome
Ramón Cueto, Wen Shen, Lu Liu, et al.
Redox Biology (2024) Vol. 73, pp. 103139-103139
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top